Business warfare: latest responses from both sides, Huaxi Biotech: opposes "name games" involving ingredients.

The controversy over the composition of giant biological products is still ongoing. On June 4th, Giant Biology officially disclosed the test results of the recombinant collagen protein product. It mentioned that four testing institutions used different testing methods, and the final results showed that the content of components was all greater than 0.1%. At the same time, the company denied "false advertising". Huaxi Biology responded to this: the safety and prosperity of an industry require the participation of testing institutions, professionals, media, and other ecological partners. It requires an environment that does not treat whistleblowers as rumor mongers. The melamine incident is not due to a lack of technology for detecting this harmful substance, but rather due to unethical companies exploiting loopholes in testing standards. Today, we must prevent individual companies from colluding with a few impure scholars to manipulate standard discussions and create standards that benefit a few companies at the expense of the entire industry's development and society as a whole. Using "battle of standards" and "business battle" to conceal a company's basic product safety and value commitments.